1. Metabolic Engineering of Escherichia coli for Production of Polyhydroxyalkanoates with Hydroxyvaleric Acid Derived from Levulinic Acid
- Author
-
Sung Kuk Lee and Doyun Kim
- Subjects
biology ,Cupriavidus necator ,General Medicine ,biology.organism_classification ,medicine.disease_cause ,Applied Microbiology and Biotechnology ,Polyhydroxyalkanoates ,Pseudomonas putida ,Metabolic engineering ,Metabolic pathway ,chemistry.chemical_compound ,chemistry ,Levulinic acid ,medicine ,Food science ,Chromobacterium violaceum ,Escherichia coli ,Biotechnology - Abstract
Polyhydroxyalkanoates (PHAs) are emerging as alternatives to plastics by replacing fossil fuels with renewable raw substrates. Herein, we present the construction of engineered Escherichia coli strains to produce short-chain-length PHAs (scl-PHAs), including the monomers 4-hydroxyvalerate (4HV) and 3-hydroxyvalerate (3HV) produced from levulinic acid (LA). First, an E. coli strain expressing genes (lvaEDABC) from the levulinic acid metabolic pathway of Pseudomonas putida KT2440 was constructed to generate 4HV-CoA and 3HV-CoA. Second, both PhaAB enzymes from Cupriavidus necator H16 were expressed to supply 3-hydroxybutyrate (3HB)-CoA from acetyl-CoA. Finally, PHA synthase (PhaCCv) from Chromobacterium violaceum was introduced for the subsequent polymerization of these three monomers. The resulting E. coli strains produced four PHAs (w/w% of dry cell weight): 9.1 wt% P(4HV), 1.7 wt% P(3HV-co-4HV), 24.2 wt% P(3HB-co-4HV), and 35.6 wt% P(3HB-co-3HV-co-4HV).
- Published
- 2022
- Full Text
- View/download PDF